Vanguard Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $49.7B | Buy |
240,349,660
+3,731,074
| +2% | +$738M | 0.72% | 15 |
|
|
2025
Q3 | $43.9B | Sell |
236,618,586
-429,273
| -0.2% | -$73.5M | 0.66% | 19 |
|
|
2025
Q2 | $36.2B | Buy |
237,047,859
+3,085,180
| +1% | +$474M | 0.59% | 20 |
|
|
2025
Q1 | $38.8B | Buy |
233,962,679
+1,170,120
| +0.5% | +$183M | 0.7% | 19 |
|
|
2024
Q4 | $33.7B | Buy |
232,792,559
+1,772,706
| +0.8% | +$275M | 0.59% | 21 |
|
|
2024
Q3 | $37.4B | Buy |
231,019,853
+1,978,057
| +0.9% | +$315M | 0.67% | 19 |
|
|
2024
Q2 | $33.5B | Buy |
229,041,796
+103,292
| +0% | +$15.4M | 0.64% | 19 |
|
|
2024
Q1 | $36.2B | Sell |
228,938,504
-449,167
| -0.2% | -$71.5M | 0.72% | 18 |
|
|
2023
Q4 | $36B | Buy |
229,387,671
+100,936
| +0% | +$15.5M | 0.79% | 16 |
|
|
2023
Q3 | $35.7B | Sell |
229,286,735
-18,192,091
| -7% | -$3B | 0.88% | 14 |
|
|
2023
Q2 | $41B | Buy |
247,478,826
+548,469
| +0.2% | +$88.5M | 0.97% | 11 |
|
|
2023
Q1 | $38.3B | Buy |
246,930,357
+103,736
| +0% | +$16.8M | 0.97% | 12 |
|
|
2022
Q4 | $43.6B | Buy |
246,826,621
+1,485,746
| +0.6% | +$257M | 1.19% | 5 |
|
|
2022
Q3 | $40.1B | Buy |
245,340,875
+2,815,655
| +1% | +$476M | 1.18% | 8 |
|
|
2022
Q2 | $43.1B | Buy |
242,525,220
+4,384,110
| +2% | +$781M | 1.21% | 7 |
|
|
2022
Q1 | $42.2B | Buy |
238,141,110
+3,358,478
| +1% | +$571M | 1% | 9 |
|
|
2021
Q4 | $40.2B | Buy |
234,782,632
+1,303,457
| +0.6% | +$213M | 0.91% | 10 |
|
|
2021
Q3 | $37.7B | Buy |
233,479,175
+2,046,807
| +0.9% | +$349M | 0.94% | 10 |
|
|
2021
Q2 | $38.1B | Buy |
231,432,368
+1,701,721
| +0.7% | +$282M | 0.95% | 10 |
|
|
2021
Q1 | $37.8B | Buy |
229,730,647
+1,784,543
| +0.8% | +$289M | 1.02% | 9 |
|
|
2020
Q4 | $35.9B | Sell |
227,946,104
-1,038,506
| -0.5% | -$153M | 1.04% | 8 |
|
|
2020
Q3 | $34.1B | Sell |
228,984,610
-2,762,898
| -1% | -$409M | 1.13% | 5 |
|
|
2020
Q2 | $32.6B | Sell |
231,747,508
-2,068,630
| -0.9% | -$301M | 1.16% | 6 |
|
|
2020
Q1 | $30.7B | Buy |
233,816,138
+5,518,363
| +2% | +$783M | 1.31% | 5 |
|
|
2019
Q4 | $33.3B | Buy |
228,297,775
+2,265,201
| +1% | +$307M | 1.14% | 6 |
|
|
2019
Q3 | $29.2B | Buy |
226,032,574
+873,586
| +0.4% | +$115M | 1.08% | 7 |
|
|
2019
Q2 | $31.4B | Buy |
225,158,988
+1,627,370
| +0.7% | +$225M | 1.18% | 5 |
|
|
2019
Q1 | $31.2B | Buy |
223,531,618
+2,207,044
| +1% | +$296M | 1.23% | 4 |
|
|
2018
Q4 | $28.6B | Buy |
221,324,574
+7,891,125
| +4% | +$1.1B | 1.28% | 4 |
|
|
2018
Q3 | $29.5B | Buy |
213,433,449
+3,235,861
| +2% | +$430M | 1.15% | 4 |
|
|
2018
Q2 | $25.5B | Buy |
210,197,588
+2,804,652
| +1% | +$350M | 1.07% | 7 |
|
|
2018
Q1 | $26.6B | Buy |
207,392,936
+2,926,410
| +1% | +$396M | 1.16% | 6 |
|
|
2017
Q4 | $28.6B | Buy |
204,466,526
+2,645,440
| +1% | +$368M | 1.25% | 5 |
|
|
2017
Q3 | $26.2B | Buy |
201,821,086
+1,370,101
| +0.7% | +$182M | 1.23% | 5 |
|
|
2017
Q2 | $26.5B | Buy |
200,450,985
+3,023,110
| +2% | +$386M | 1.31% | 3 |
|
|
2017
Q1 | $24.6B | Buy |
197,427,875
+6,239,131
| +3% | +$745M | 1.26% | 3 |
|
|
2016
Q4 | $22B | Buy |
191,188,744
+2,529,867
| +1% | +$292M | 1.23% | 4 |
|
|
2016
Q3 | $22.3B | Buy |
188,658,877
+4,146,225
| +2% | +$503M | 1.31% | 4 |
|
|
2016
Q2 | $22.4B | Buy |
184,512,652
+3,924,090
| +2% | +$446M | 1.39% | 4 |
|
|
2016
Q1 | $19.5B | Buy |
180,588,562
+5,195,469
| +3% | +$538M | 1.27% | 4 |
|
|
2015
Q4 | $18B | Buy |
175,393,093
+3,680,649
| +2% | +$370M | 1.21% | 4 |
|
|
2015
Q3 | $16B | Buy |
171,712,444
+1,784,429
| +1% | +$173M | 1.16% | 5 |
|
|
2015
Q2 | $16.6B | Buy |
169,928,015
+1,032,227
| +0.6% | +$103M | 1.12% | 5 |
|
|
2015
Q1 | $17B | Buy |
168,895,788
+5,032,716
| +3% | +$512M | 1.15% | 5 |
|
|
2014
Q4 | $17.1B | Buy |
163,863,072
+4,465,862
| +3% | +$471M | 1.23% | 4 |
|
|
2014
Q3 | $17B | Buy |
159,397,210
+3,037,249
| +2% | +$315M | 1.32% | 5 |
|
|
2014
Q2 | $16.4B | Buy |
156,359,961
+4,705,813
| +3% | +$476M | 1.29% | 4 |
|
|
2014
Q1 | $14.9B | Buy |
151,654,148
+12,365,888
| +9% | +$1.15B | 1.25% | 5 |
|
|
2013
Q4 | $12.8B | Buy |
139,288,260
+2,465,674
| +2% | +$227M | 1.12% | 7 |
|
|
2013
Q3 | $11.9B | Buy |
136,822,586
+4,225,966
| +3% | +$379M | 1.16% | 5 |
|
|
2013
Q2 | $11.4B | Buy |
+132,596,620
| New | +$11.3B | 1.2% | 5 |
|
Other funds holding JNJ
Vanguard Group's JNJ Position: Q4 2025 in Review
Vanguard Group increased its Johnson & Johnson (JNJ) stake by 1.6% in Q4 2025, buying an estimated $738M and bringing the position to 240,349,660 shares worth $49.7B. The position accounts for 0.72% of the portfolio, ranked #15.
Vanguard Group first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.
- Vanguard Group held 240,349,660 shares of Johnson & Johnson worth $49.7B as of Q4 2025.
- Vanguard Group bought 3,731,074 Johnson & Johnson shares in Q4 2025, an estimated $738M.
- Johnson & Johnson made up 0.72% of Vanguard Group's portfolio in Q4 2025, its #15 holding.
- Vanguard Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
- 4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.